NCT05759676View on ClinicalTrials.gov

Efficacy and Safety of Polymer-free Amphilimus-eluting Stent According to the Diabetes

RecruitingOBSERVATIONAL

Enrollment

1,800

Participants

Timeline

Start Date

March 9, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions

Diabetes MellitusCoronary Artery Disease

Interventions

DEVICE

Cre8™/Cre8™ EVO drug-eluting stent

Patient with CAD who undergoing PCI with Cre8™/Cre8™ EVO drug-eluting stent

Trial Locations (1)

136-705

RECRUITING

Korea University Anam Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Diomedical

UNKNOWN

lead

Korea University Anam Hospital

OTHER